Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?

Gunnar Henrik Heine1, Vincent Brandenburg2

  • 1Saarland University Medical Center, Saarland University Faculty of Medicine, Internal Medicine IV-Nephrology and Hypertension, Homburg, Germany.

Kidney International
|March 19, 2017
PubMed

Insights

Oral anticoagulants in advanced chronic kidney disease patients with atrial fibrillation did not prevent strokes or cause bleeding but did prolong life. Further randomized trials are needed to clarify optimal treatment strategies.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation management in advanced chronic kidney disease (CKD) is challenging.
  • Evidence for oral anticoagulant therapy (OAT) in this population is limited and controversial.
  • Observational studies provide conflicting results regarding OAT efficacy and safety in CKD patients.

Purpose of the Study:

  • To investigate the effects of OAT on ischemic stroke, hemorrhage, and survival in elderly patients with advanced CKD and atrial fibrillation.
  • To evaluate the real-world outcomes of OAT in a specific high-risk patient cohort.

Main Methods:

  • Retrospective analysis of a Canadian health care system database.
  • Inclusion of elderly patients with advanced CKD and atrial fibrillation.
  • Comparison of outcomes between patients receiving OAT and those not receiving OAT.

Main Results:

  • OAT did not significantly reduce the incidence of ischemic strokes.
  • OAT was associated with an increased risk of induced hemorrhages.
  • OAT demonstrated a survival benefit, prolonging life in the studied population.

Conclusions:

  • The findings present a paradoxical effect of OAT in advanced CKD patients with atrial fibrillation.
  • The results highlight the urgent need for robust, randomized controlled trials to establish definitive guidelines.
  • Further research is crucial to balance the risks and benefits of OAT in this complex patient group.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
419
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
505
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.9K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
434